IP Library › Granted Patent US 7,368,528
Granted Patent B2
US 7,368,528 · App. 11/179,074 · Granted May 6, 2008

Antineoplastic peptides

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,368,528
App. No.
11/179,074
Granted
May 6, 2008
Kind
B2
Abstract

The present invention provides antineoplastic peptides of formula I, R 1 R 2 N—CHX—CO-A-B-D-E-(G) s -K I wherein R 1 , R 2 , X, A, B, D, E, G, K, and s have the meanings stated in the description. The compounds have antineoplastic activity.

Claims (4)

1. A synthesized peptide of the formula I:

Me 2 Val-Val-MeVal-Pro-Pro-NHC(CH 3 ) 3 (SEQ ID NO: 1)  (I)

and the salt thereof with physiologically tolerated acids.

2. The peptide of claim 1 wherein the peptide of formula I is in the hydrochloride form.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2013
From: ABBOTT GMBH & CO KG
To: ABBVIE DEUTSCHLAND GMBH & CO KG
Reel/Frame 030805/0023 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2008
From: BASF AKTIENGESELLSCHAFT
To: ABBOTT GMBH & CO. KG
Reel/Frame 020635/0232 →